Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 948308, 3 pages
http://dx.doi.org/10.1155/2013/948308
Editorial

Integrating Complementary and Alternative Medicine with Primary Health Care

1Gulf Medical University, Ajman, UAE
2Dabur International Ltd., Jebel Ali Free Zone, Dubai, UAE
3Pharmacognosy Department, National Botanical Research Institute, Lucknow, India

Received 24 June 2013; Accepted 24 June 2013

Copyright © 2013 Annie Shirwaikar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ernst, K. L. Resch, S. Mills et al., “Complementary medicine—a definition,” British Journal of General Practice, vol. 45, article 506, 1995. View at Google Scholar
  2. J. Barnes, N. C. Abbot, E. F. Harkness, and E. Ernst, “Articles on complementary medicine in the mainstream medical literature,” Archives of Internal Medicine, vol. 159, no. 15, pp. 1721–1725, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. “Report on complementary medicines,” Tech. Rep., Mintel, London, UK, 1997.
  4. P. Brevoort, “The booming US botanical market: a new overview,” Herbal Gram, vol. 44, pp. 33–48, 1998. View at Google Scholar
  5. D. M. Eisenberg, R. C. Kessler, C. Foster, F. E. Norlock, D. R. Calkins, and T. L. Delbanco, “Unconventional medicine in the United States—Prevalence, costs, and patterns of use,” The New England Journal of Medicine, vol. 328, no. 4, pp. 246–252, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. L. C. Paramore, “Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey,” Journal of Pain and Symptom Management, vol. 13, no. 2, pp. 83–89, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. Landmark Healthcare, “The Landmark report on oublic perceptions of alternative care,” Tech. Rep., Landmark Healthcare, Sacramento, Calif, USA, 1998. View at Google Scholar
  8. K. R. Pelletier, A. Marie, M. Krasner, and W. L. Haskell, “Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers,” American Journal of Health Promotion, vol. 12, no. 2, pp. 112–123, 1997. View at Google Scholar · View at Scopus
  9. M. S. Wetzel, D. M. Eisenberg, and T. J. Kaptchuk, “Courses involving complementary and alternative medicine at US medical schools,” Journal of the American Medical Association, vol. 280, no. 9, pp. 784–787, 1998. View at Google Scholar · View at Scopus
  10. P. Fisher and A. Ward, “Complementary medicine in Europe,” British Medical Journal, vol. 309, no. 6947, pp. 107–111, 1994. View at Google Scholar · View at Scopus
  11. A. H. MacLennan, D. H. Wilson, and A. W. Taylor, “Prevalence and cost of alternative medicine in Australia,” Lancet, vol. 347, no. 9001, pp. 569–573, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Eisenberg, R. C. Kessler, C. Foster, F. E. Norlock, D. R. Calkins, and T. L. Delbanco, “Unconventional medicine in the United States—Prevalence, costs, and patterns of use,” The New England Journal of Medicine, vol. 328, no. 4, pp. 246–252, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Eisenberg, R. B. Davis, S. L. Ettner et al., “Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1569–1575, 1998. View at Google Scholar · View at Scopus
  14. R. C. Kessler, R. B. Davis, D. F. Foster et al., “Long-term trends in the use of complementary and alternative medical therapies in the United States,” Annals of Internal Medicine, vol. 135, no. 4, pp. 262–268, 2001. View at Google Scholar · View at Scopus
  15. R. Govindarajan, M. Vijayakumar, and P. Pushpangadan, “Antioxidant approach to disease management and the role of 'Rasayana' herbs of Ayurveda,” Journal of Ethnopharmacology, vol. 99, no. 2, pp. 165–178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. “New model guidelines for the use of complementary and alternative therapies in medical practice,” Alternative Therapies in Health and Medicine, vol. 8, pp. 44–47, 2002.
  17. E. Ernst and B. R. Cassileth, “The prevalence of complementary/alternative medicine in cancer: a systematic review,” Cancer, vol. 83, pp. 777–782, 1998. View at Google Scholar
  18. R. S. Dipaola, H. Zhang, G. H. Lambert et al., “Clinical and biologic activity of an estrogenic herbal combination (PC- SPES) in prostate cancer,” The New England Journal of Medicine, vol. 339, no. 12, pp. 785–791, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Coppes, R. A. Anderson, R. M. Egeler, and J. E. A. Wolff, “Alternative therapies for the treatment of childhood cancer,” The New England Journal of Medicine, vol. 339, no. 12, pp. 846–847, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Angell and J. P. Kassirer, “Alternative medicine—the risks of untested and unregulated remedies,” The New England Journal of Medicine, vol. 339, no. 12, pp. 839–841, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Coss, P. McGrath, and V. Caggiano, “Alternative care: patient choices for adjunct therapies within a cancer center,” Cancer Practice, vol. 6, no. 3, pp. 176–181, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. “World Health Organization medicines Strategy 2002–2005,” http://whqlibdoc.who.int/hq/2002/who_edm_trm_2002.1.pdf.
  23. B. Patwardhan, A. D. B. Vaidya, and M. Chorghade, “Ayurveda and natural products drug discovery,” Current Science, vol. 86, no. 6, pp. 789–799, 2004. View at Google Scholar · View at Scopus
  24. J. M. Rollinger, S. Haupt, H. Stuppner, and T. Langer, “Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example,” Journal of Chemical Information and Computer Sciences, vol. 44, no. 2, pp. 480–488, 2004. View at Google Scholar · View at Scopus
  25. B. Patwardhan, “Ayurveda: the “Designer” medicine: a review of ethnopharmacology and bioprospecting research,” Indian Drugs, vol. 37, no. 5, pp. 213–227, 2000. View at Google Scholar · View at Scopus